Pevonedistat also showed increased cytotoxic effects in VEXAS cells (IC50 553 nM) compared to MDS (1048 nM, p = 0.0004) and healthy CD34+ cells (1107 nM, p = 0.0002) (Figure 1C,D). The gene discussed is CD34; the disease is myelodysplastic syndrome.